REVUMENIB 25 MG TABLET

🧪 Composition

• Active Ingredient: Revumenib
• Dosage Form: Oral Tablet
• Strength: 25 mg

✅ Uses

• Used for the treatment of relapsed or refractory acute leukemia with KMT2A (MLL) gene rearrangement in eligible patients.
• Helps inhibit the growth and survival of abnormal leukemia cells.
• Supports disease control in patients with genetically defined acute leukemia.
• Used as part of a personalized treatment plan based on molecular diagnostic testing.

💉 Dosage

Take Revumenib 25 mg exactly as prescribed by your healthcare provider. The dosage is determined based on the patient’s medical condition, body weight, concurrent medications, and treatment response. Follow the prescribed schedule carefully and do not alter or discontinue therapy without medical advice.

⚠️ Precautions

• Use only under the supervision of a qualified healthcare professional.
• Regular monitoring of blood counts, liver function, heart rhythm (ECG), and electrolyte levels may be required during treatment.
• Inform your doctor about any liver disease, heart conditions, or other ongoing medical problems before starting therapy.
• Report symptoms such as fever, unusual bleeding, severe fatigue, dizziness, or irregular heartbeat immediately.

📦 Storage

Store the tablets at room temperature in a cool, dry place away from moisture, heat, and direct sunlight. Keep the medicine in its original packaging and out of the reach of children.

⭐ Conclusion

Revumenib 25 mg is an innovative targeted therapy for eligible patients with KMT2A-rearranged relapsed or refractory acute leukemia. When used under specialist supervision and guided by appropriate genetic testing, it can help manage disease progression and support improved treatment outcomes. Always follow your healthcare provider’s recommendations for safe and effective use.